UK Stroke Forum Supplement - February 2024 - 117

Abstracts
117
Minutes Of Activity Which Is Captured In-App, Based On User Interaction
During A Workout. Secondary Outcomes Were Determined Using
Separate Questionnaires For Clinicians And Participants Completed At
The End Of The Study.
Results: User Testing And Feedback Indicated That Rewire Helps To
Increase Weekly Activity By Around 90 Minutes On Average. Recruitment
Has Just Begun At The Time Of Abstract Submission, Aiming For 25-30
Participants During A Six Month Period.
Conclusion: Awaiting Results.
Rehabilitation (Service Development)
Conversational Rehabilitation - Unlocking The Keys
To Self Directed Around The Clock Rehabilitation -
Making Every Moment Matter In Stroke Recovery
L. Luxton
Northampton General Hospital
Introduction: Assisting Patients To Self-Direct Their Rehabilitation Can
Be Challenging. Conversational Rehabilitation Is A Term Used To
Describe The Intervention Of Coaching Patients Towards Self-Directed
Rehabilitation. The Team Developed A Pathway Model To Assist Patients
To Move From Crisis, Cope, And Coast To An Ethos Of Create And
Conquer Around Their Rehabilitation Journey So That They Can Live
Meaningful And Fulfilling Lives Beyond Their Stroke. The Team Also
Developed Tools And Techniques To Support Patients With Trauma,
Anxiety, And Grief Post Stroke.
Method: Sixty-Five Professionals Across The Stroke Pathway Completed
A Cpd Accredited, 2-Year, Practical, Training Programme, To Upskill
Them To Deliver Conversational Rehabilitation Coaching. Patients Were
Coached During Everyday Interactions And Therapy Sessions In How To
Unlock The 8 Keys To Recovery Which Included, Mindset, Social
Connections, Time, Identity, Spirituality, Environment, Physical Health,
And Emotional Awareness. Level 3 Coaching Was Provided Remotely For
Patients By Trained External Therapists. Patients With Cognitive And
Behavioural Needs Still Accessed Psychology Via The Previous Model.
Alongside Coaching, Therapists Utilise A Variety Of Tools And Techniques
Including Breathing, Meditations, Visualisations, Mental Rehearsal, And
Remote Wellbeing Groups To Help Patients To Self-Manage Their
Condition.
Results: All Patients Reduced Their Levels Of Depression And Anxiety
Significantly, Length Of Stay Reduced, Especially For Those Identified As
Level 2 And 3 Psychological Need, Patient Satisfaction Remained High,
And More Patients Achieved Their Goals.
Conclusion:
This
Model
Seamlessly
Shows That Conversational
Rehabilitation Coaching Can Improve Patient Outcomes Significantly And
Is Safe, Feasible And Effective For The Mdt To Deliver.
-
Rehabilitation (Service Development)
Novel Use Of Stroke Specific Carers To Assist In
The Delivery Of Mdt Rehab In A Small Esd Service
C. Buttery, I. Eva, A. Abed, D. Andrews, K. Farrow, H. Day
Maidstone And Tunbridge Wells NHS Trust, Maidstone And Tunbridge Wells
NHS Trust, Maidstone And Tunbridge Wells NHS Trust, Maidstone And
Tunbridge Wells NHS Trust, Maidstone And Tunbridge Wells NHS Trust,
Maidstone And Tunbridge Wells NHS Trust
Introduction: Stroke Guidelines Suggest That Stroke Survivors Should
Receive Intensive Mdt Therapy In The Home Setting In Order To Achieve
Optimal Functional Outcomes. Esd Services Often Struggle To Provide
This Level Of Rehabilitation. Furthermore, The Stroke Association
Report That Stroke Survivors Often Feel Abandoned When Leaving The
Acute Hospital. This Service Evaluation Explores The Use Of Stroke
Specific Carers In A Small Esd Service, Measuring Intensity Of Therapy
And How This Affects Patient Function.
Method: A Modified Esd Service Was Setup And Overseen By Therapists,
Discharge Liaison Services And In Collaboration With A Care Provider
And Social Services. The Carers Were Provided With Stroke Specific
Training
Enabling
Facilitation Of Stroke Rehabilitation Under The
Guidance Of Therapists. Therapists Prescribed All Exercise And Task
Practice For Carers To Follow And Reviewed The Patients Regularly To
Progress As Appropriate. The Service Was Reviewed Through Evaluation
Of Therapy Intensity (Ssnap Data), Function And Impairment Based
Outcomes (Toms, Barthel And Mrs) And Patient Feedback.
Results: The Full Results Of This Service Evaluation Are Pending, But
Preliminary Results Indicate That Patients Receive Higher Than The
National Average Therapy Input When Compared To Ssnap Data. The
Patients Are Demonstrating Improvements At A Functional And
Impairment Level. Overall Patient Feedback Is Positive.
Conclusion: The Use Of Stroke Specific Carers To Increase Therapy
Intensity Enabled The Service To Exceed Ssnap Guidance For Therapy
Intervention. The Reduction In Patient Disability And Increase In Function,
Supports The Use Of Carers To Support Therapy Provision In This Esd
Service.
Rehabilitation (Service Development)
Northamptonshire Community Stroke Team -
Working In Partnership With Our Patients So They
Can Live Meaningful, Fulfilling And Enjoyable Lives
Beyond Their Stroke
L. Luxton
Northampton General Hospital
Introduction: The Northamptonshire Community Stroke Team (N-Cst)
Is Nationally Acclaimed As A Leading Example Of An Integrated Stroke
Service (Icss) Model, Providing Stroke Specialist, 7 Day A Week, Needs
Based, Community Rehabilitation. N-Cst Was One Of Three Pilots To
Assist NHSe/I In The Development And Validation Of This Icss Model.
Method: N-Cst Were Mostly Compliant With The Icss Model. However,
Over An 18-Month Period The Team Developed An Enhanced Service
Model Which Included:
- An In-House Cst Reablement Service That Provides Therapeutic
Reablement Care At Home Within 24 Hours Of Discharge
- A Vocational Rehabilitation Service To Assist Patients To Return
To Work
-
A Patient And Family Support Service Of Patient Volunteers, A
Patient Forum, An Online Community Network 'My Stroke
Hub', Peer Support Workers And Remote And Face To Face
Wellbeing And Support Groups
A 'Self-Directed Rehabilitation Pathway' That Provided Training
To All Mdt Staff Across Entire Stroke Pathway To Deliver
Conversational
Rehabilitation Coaching To Patients
Wellbeing And Self-Management.
Results: Patients Received A Responsive, Intensive, Needs Based
Service. Patients Are Seen Within 24 Hours For Care, Previously 5
Weeks And 48 Hours For Wellbeing Support, Previously One Year. Over
90% Of Patients Achieve Their Rehabilitation Goals. 90% Of Patients
Maintained Their Employment Status. Patients Are Seen Within 14 Days
For Peer Support And Secondary Prevention. The Team Have 300
Patients On Their Bespoke Education Platform - Georges Place. Via
Survey, 99% Of Patients
State
That Our Service Exceeds
Their
Expectations.
Conclusion: This Project Has Shown How Coordinated Seamless Care,
Delivered By One Team Can Produce Excellent Patient Outcomes And
The Service Has Been Substantively Funded To Continue By
Commissioners, Being A First Of Its Kind Service.
International Journal of Stroke, 19(1S)
For

UK Stroke Forum Supplement - February 2024

Table of Contents for the Digital Edition of UK Stroke Forum Supplement - February 2024

Contents
UK Stroke Forum Supplement - February 2024 - CT1
UK Stroke Forum Supplement - February 2024 - CT2
UK Stroke Forum Supplement - February 2024 - Cover1
UK Stroke Forum Supplement - February 2024 - Cover2
UK Stroke Forum Supplement - February 2024 - Contents
UK Stroke Forum Supplement - February 2024 - 2
UK Stroke Forum Supplement - February 2024 - 3
UK Stroke Forum Supplement - February 2024 - 4
UK Stroke Forum Supplement - February 2024 - 5
UK Stroke Forum Supplement - February 2024 - 6
UK Stroke Forum Supplement - February 2024 - 7
UK Stroke Forum Supplement - February 2024 - 8
UK Stroke Forum Supplement - February 2024 - 9
UK Stroke Forum Supplement - February 2024 - 10
UK Stroke Forum Supplement - February 2024 - 11
UK Stroke Forum Supplement - February 2024 - 12
UK Stroke Forum Supplement - February 2024 - 13
UK Stroke Forum Supplement - February 2024 - 14
UK Stroke Forum Supplement - February 2024 - 15
UK Stroke Forum Supplement - February 2024 - 16
UK Stroke Forum Supplement - February 2024 - 17
UK Stroke Forum Supplement - February 2024 - 18
UK Stroke Forum Supplement - February 2024 - 19
UK Stroke Forum Supplement - February 2024 - 20
UK Stroke Forum Supplement - February 2024 - 21
UK Stroke Forum Supplement - February 2024 - 22
UK Stroke Forum Supplement - February 2024 - 23
UK Stroke Forum Supplement - February 2024 - 24
UK Stroke Forum Supplement - February 2024 - 25
UK Stroke Forum Supplement - February 2024 - 26
UK Stroke Forum Supplement - February 2024 - 27
UK Stroke Forum Supplement - February 2024 - 28
UK Stroke Forum Supplement - February 2024 - 29
UK Stroke Forum Supplement - February 2024 - 30
UK Stroke Forum Supplement - February 2024 - 31
UK Stroke Forum Supplement - February 2024 - 32
UK Stroke Forum Supplement - February 2024 - 33
UK Stroke Forum Supplement - February 2024 - 34
UK Stroke Forum Supplement - February 2024 - 35
UK Stroke Forum Supplement - February 2024 - 36
UK Stroke Forum Supplement - February 2024 - 37
UK Stroke Forum Supplement - February 2024 - 38
UK Stroke Forum Supplement - February 2024 - 39
UK Stroke Forum Supplement - February 2024 - 40
UK Stroke Forum Supplement - February 2024 - 41
UK Stroke Forum Supplement - February 2024 - 42
UK Stroke Forum Supplement - February 2024 - 43
UK Stroke Forum Supplement - February 2024 - 44
UK Stroke Forum Supplement - February 2024 - 45
UK Stroke Forum Supplement - February 2024 - 46
UK Stroke Forum Supplement - February 2024 - 47
UK Stroke Forum Supplement - February 2024 - 48
UK Stroke Forum Supplement - February 2024 - 49
UK Stroke Forum Supplement - February 2024 - 50
UK Stroke Forum Supplement - February 2024 - 51
UK Stroke Forum Supplement - February 2024 - 52
UK Stroke Forum Supplement - February 2024 - 53
UK Stroke Forum Supplement - February 2024 - 54
UK Stroke Forum Supplement - February 2024 - 55
UK Stroke Forum Supplement - February 2024 - 56
UK Stroke Forum Supplement - February 2024 - 57
UK Stroke Forum Supplement - February 2024 - 58
UK Stroke Forum Supplement - February 2024 - 59
UK Stroke Forum Supplement - February 2024 - 60
UK Stroke Forum Supplement - February 2024 - 61
UK Stroke Forum Supplement - February 2024 - 62
UK Stroke Forum Supplement - February 2024 - 63
UK Stroke Forum Supplement - February 2024 - 64
UK Stroke Forum Supplement - February 2024 - 65
UK Stroke Forum Supplement - February 2024 - 66
UK Stroke Forum Supplement - February 2024 - 67
UK Stroke Forum Supplement - February 2024 - 68
UK Stroke Forum Supplement - February 2024 - 69
UK Stroke Forum Supplement - February 2024 - 70
UK Stroke Forum Supplement - February 2024 - 71
UK Stroke Forum Supplement - February 2024 - 72
UK Stroke Forum Supplement - February 2024 - 73
UK Stroke Forum Supplement - February 2024 - 74
UK Stroke Forum Supplement - February 2024 - 75
UK Stroke Forum Supplement - February 2024 - 76
UK Stroke Forum Supplement - February 2024 - 77
UK Stroke Forum Supplement - February 2024 - 78
UK Stroke Forum Supplement - February 2024 - 79
UK Stroke Forum Supplement - February 2024 - 80
UK Stroke Forum Supplement - February 2024 - 81
UK Stroke Forum Supplement - February 2024 - 82
UK Stroke Forum Supplement - February 2024 - 83
UK Stroke Forum Supplement - February 2024 - 84
UK Stroke Forum Supplement - February 2024 - 85
UK Stroke Forum Supplement - February 2024 - 86
UK Stroke Forum Supplement - February 2024 - 87
UK Stroke Forum Supplement - February 2024 - 88
UK Stroke Forum Supplement - February 2024 - 89
UK Stroke Forum Supplement - February 2024 - 90
UK Stroke Forum Supplement - February 2024 - 91
UK Stroke Forum Supplement - February 2024 - 92
UK Stroke Forum Supplement - February 2024 - 93
UK Stroke Forum Supplement - February 2024 - 94
UK Stroke Forum Supplement - February 2024 - 95
UK Stroke Forum Supplement - February 2024 - 96
UK Stroke Forum Supplement - February 2024 - 97
UK Stroke Forum Supplement - February 2024 - 98
UK Stroke Forum Supplement - February 2024 - 99
UK Stroke Forum Supplement - February 2024 - 100
UK Stroke Forum Supplement - February 2024 - 101
UK Stroke Forum Supplement - February 2024 - 102
UK Stroke Forum Supplement - February 2024 - 103
UK Stroke Forum Supplement - February 2024 - 104
UK Stroke Forum Supplement - February 2024 - 105
UK Stroke Forum Supplement - February 2024 - 106
UK Stroke Forum Supplement - February 2024 - 107
UK Stroke Forum Supplement - February 2024 - 108
UK Stroke Forum Supplement - February 2024 - 109
UK Stroke Forum Supplement - February 2024 - 110
UK Stroke Forum Supplement - February 2024 - 111
UK Stroke Forum Supplement - February 2024 - 112
UK Stroke Forum Supplement - February 2024 - 113
UK Stroke Forum Supplement - February 2024 - 114
UK Stroke Forum Supplement - February 2024 - 115
UK Stroke Forum Supplement - February 2024 - 116
UK Stroke Forum Supplement - February 2024 - 117
UK Stroke Forum Supplement - February 2024 - 118
UK Stroke Forum Supplement - February 2024 - 119
UK Stroke Forum Supplement - February 2024 - 120
UK Stroke Forum Supplement - February 2024 - 121
UK Stroke Forum Supplement - February 2024 - 122
UK Stroke Forum Supplement - February 2024 - 123
UK Stroke Forum Supplement - February 2024 - 124
UK Stroke Forum Supplement - February 2024 - 125
UK Stroke Forum Supplement - February 2024 - 126
UK Stroke Forum Supplement - February 2024 - 127
UK Stroke Forum Supplement - February 2024 - 128
UK Stroke Forum Supplement - February 2024 - 129
UK Stroke Forum Supplement - February 2024 - 130
UK Stroke Forum Supplement - February 2024 - 131
UK Stroke Forum Supplement - February 2024 - 132
UK Stroke Forum Supplement - February 2024 - 133
UK Stroke Forum Supplement - February 2024 - 134
UK Stroke Forum Supplement - February 2024 - 135
UK Stroke Forum Supplement - February 2024 - 136
UK Stroke Forum Supplement - February 2024 - 137
UK Stroke Forum Supplement - February 2024 - 138
UK Stroke Forum Supplement - February 2024 - 139
UK Stroke Forum Supplement - February 2024 - 140
UK Stroke Forum Supplement - February 2024 - 141
UK Stroke Forum Supplement - February 2024 - 142
UK Stroke Forum Supplement - February 2024 - 143
UK Stroke Forum Supplement - February 2024 - 144
UK Stroke Forum Supplement - February 2024 - Cover3
UK Stroke Forum Supplement - February 2024 - Cover4
https://europe.nxtbook.com/nxteu/sageuk/wso_202404
https://europe.nxtbook.com/nxteu/sageuk/ukstrokeforum_202402_supp
https://europe.nxtbook.com/nxteu/sageuk/wso_202403
https://europe.nxtbook.com/nxteu/sageuk/wso_202402
https://europe.nxtbook.com/nxteu/sageuk/wso_202401
https://europe.nxtbook.com/nxteu/sageuk/wso_2023123_US_UKOnly
https://europe.nxtbook.com/nxteu/sageuk/wso_2023123_ROW
https://europe.nxtbook.com/nxteu/sageuk/wso_2023101
https://europe.nxtbook.com/nxteu/sageuk/wso_202308
https://europe.nxtbook.com/nxteu/sageuk/wso_202307
https://europe.nxtbook.com/nxteu/sageuk/wso_202306
https://europe.nxtbook.com/nxteu/sageuk/wso_202304
https://europe.nxtbook.com/nxteu/sageuk/wso_202303
https://europe.nxtbook.com/nxteu/sageuk/wso_202302
https://europe.nxtbook.com/nxteu/sageuk/wso_202301
https://www.nxtbookmedia.com